These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20216476)

  • 1. PACdb: a database for cell-based pharmacogenomics.
    Gamazon ER; Duan S; Zhang W; Huang RS; Kistner EO; Dolan ME; Cox NJ
    Pharmacogenet Genomics; 2010 Apr; 20(4):269-73. PubMed ID: 20216476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy number polymorphisms and anticancer pharmacogenomics.
    Gamazon ER; Huang RS; Dolan ME; Cox NJ
    Genome Biol; 2011; 12(5):R46. PubMed ID: 21609475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed effects modeling of proliferation rates in cell-based models: consequence for pharmacogenomics and cancer.
    Im HK; Gamazon ER; Stark AL; Huang RS; Cox NJ; Dolan ME
    PLoS Genet; 2012 Feb; 8(2):e1002525. PubMed ID: 22346769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
    Owen RP; Altman RB; Klein TE
    Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of the G protein-coupled receptors.
    Thompson MD; Cole DE; Capra V; Siminovitch KA; Rovati GE; Burnham WM; Rana BK
    Methods Mol Biol; 2014; 1175():189-242. PubMed ID: 25150871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
    Hodge AE; Altman RB; Klein TE
    Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.
    Hartford CM; Duan S; Delaney SM; Mi S; Kistner EO; Lamba JK; Huang RS; Dolan ME
    Blood; 2009 Mar; 113(10):2145-53. PubMed ID: 19109566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.
    Stark AL; Zhang W; Mi S; Duan S; O'Donnell PH; Huang RS; Dolan ME
    Pharmacogenomics J; 2010 Dec; 10(6):505-12. PubMed ID: 20142840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AICM: A Genuine Framework for Correcting Inconsistency Between Large Pharmacogenomics Datasets.
    Hu ZT; Ye Y; Newbury PA; Huang H; Chen B
    Pac Symp Biocomput; 2019; 24():248-259. PubMed ID: 30864327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic ancestry plays a central role in population pharmacogenomics.
    Yang HC; Chen CW; Lin YT; Chu SK
    Commun Biol; 2021 Feb; 4(1):171. PubMed ID: 33547344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extraction of pharmacogenetic and pharmacogenomic relations--a case study using PharmGKB.
    Buyko E; Beisswanger E; Hahn U
    Pac Symp Biocomput; 2012; ():376-87. PubMed ID: 22174293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGMD: a comprehensive manually curated pharmacogenomic database.
    Kaplun A; Hogan JD; Schacherer F; Peter AP; Krishna S; Braun BR; Nambudiry R; Nitu MG; Mallelwar R; Albayrak A
    Pharmacogenomics J; 2016 Apr; 16(2):124-8. PubMed ID: 25939485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary pharmacogenetic assays in view of the PharmGKB database.
    Tilleman L; Weymaere J; Heindryckx B; Deforce D; Nieuwerburgh FV
    Pharmacogenomics; 2019 Mar; 20(4):261-272. PubMed ID: 30883266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines.
    Chhibber A; French CE; Yee SW; Gamazon ER; Theusch E; Qin X; Webb A; Papp AC; Wang A; Simmons CQ; Konkashbaev A; Chaudhry AS; Mitchel K; Stryke D; Ferrin TE; Weiss ST; Kroetz DL; Sadee W; Nickerson DA; Krauss RM; George AL; Schuetz EG; Medina MW; Cox NJ; Scherer SE; Giacomini KM; Brenner SE
    Pharmacogenomics J; 2017 Mar; 17(2):137-145. PubMed ID: 26856248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
    Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
    Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic Discovery Delineating the Genetic Basis of Drug Response.
    Zhang W; Zheng Y; Hou L
    Curr Genet Med Rep; 2013 Sep; 1(3):143-149. PubMed ID: 24015375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic data sample collection and storage: ethical issues and policy approaches.
    Joly Y; Knoppers BM
    Pharmacogenomics; 2006 Mar; 7(2):219-26. PubMed ID: 16515401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PolyMAPr: programs for polymorphism database mining, annotation, and functional analysis.
    Freimuth RR; Stormo GD; McLeod HL
    Hum Mutat; 2005 Feb; 25(2):110-7. PubMed ID: 15643605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic databases in pharmacogenomics: the Frequency of Inherited Disorders Database (FINDbase).
    Georgitsi M; Patrinos GP
    Methods Mol Biol; 2013; 1015():321-36. PubMed ID: 23824866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.
    Huang RS; Duan S; Bleibel WK; Kistner EO; Zhang W; Clark TA; Chen TX; Schweitzer AC; Blume JE; Cox NJ; Dolan ME
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9758-63. PubMed ID: 17537913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.